03.04.2012 • NewsCognisLonzaManagement

Lonza Appoints Richard Ridinger as New CEO

At a meeting on 2 April 2012, the Board of Directors of Lonza elected Richard Ridinger as the new CEO of Lonza. Mr. Ridinger, 53, will become CEO of Lonza effective 1 May. Rolf Soiron was acting CEO ad interim, since the end of January.

Richard Ridinger has held numerous leadership functions at Henkel for 14 years and Cognis for 11 years. Most recently, Mr. Ridinger was responsible for Care Chemicals, the largest sector at Cognis with approximately 3,000 employees. During his tenure, sales increased by 60% to €1.75 billion over six years, as he successfully repositioned the business in the market.

At the 2 April meeting, the Board of Directors also appointed Marc Funk, Group General Counsel and Board Secretary, to become a member of the Management Committee. Marc Funk joined Lonza in January 2009; prior he was associate general counsel at Merck Serono.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.